Your browser doesn't support javascript.
loading
Sorafenib Increases Tumor Hypoxia in Cervical Cancer Patients Treated With Radiation Therapy: Results of a Phase 1 Clinical Study.
Milosevic, Michael F; Townsley, Carol A; Chaudary, Naz; Clarke, Blaise; Pintilie, Melania; Fan, Stacy; Glicksman, Rachel; Haider, Masoom; Kim, Sunmo; MacKay, Helen; Yeung, Ivan; Hill, Richard P; Fyles, Anthony; Oza, Amit M.
Afiliação
  • Milosevic MF; Radiation Medicine Program, Princess Margaret Cancer Center, University Health Network, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Canada. Electronic address: mike.milosevic@rmp.uhn.ca.
  • Townsley CA; Department of Medical Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada.
  • Chaudary N; Department of Advanced Molecular Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada.
  • Clarke B; Department of Pathology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada; Department of Laboratory Medicine and Pathology, University of Toronto, Toronto, Canada.
  • Pintilie M; Department of Clinical Study Coordination and Biostatistics, Princess Margaret Cancer Center, University Health Network, Toronto, Canada.
  • Fan S; Radiation Medicine Program, Princess Margaret Cancer Center, University Health Network, Toronto, Canada.
  • Glicksman R; Radiation Medicine Program, Princess Margaret Cancer Center, University Health Network, Toronto, Canada.
  • Haider M; Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Medical Imaging, University of Toronto, Toronto, Canada.
  • Kim S; Radiation Medicine Program, Princess Margaret Cancer Center, University Health Network, Toronto, Canada.
  • MacKay H; Department of Medical Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.
  • Yeung I; Radiation Medicine Program, Princess Margaret Cancer Center, University Health Network, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Canada.
  • Hill RP; Department of Radiation Oncology, University of Toronto, Toronto, Canada; Department of Advanced Molecular Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Canada.
  • Fyles A; Radiation Medicine Program, Princess Margaret Cancer Center, University Health Network, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Canada.
  • Oza AM; Department of Medical Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada.
Int J Radiat Oncol Biol Phys ; 94(1): 111-117, 2016 Jan 01.
Article em En | MEDLINE | ID: mdl-26547383
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Compostos de Fenilureia / Carcinoma de Células Escamosas / Hipóxia Celular / Neoplasias do Colo do Útero / Niacinamida / Inibidores da Angiogênese / Quimiorradioterapia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Radiat Oncol Biol Phys Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Compostos de Fenilureia / Carcinoma de Células Escamosas / Hipóxia Celular / Neoplasias do Colo do Útero / Niacinamida / Inibidores da Angiogênese / Quimiorradioterapia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Radiat Oncol Biol Phys Ano de publicação: 2016 Tipo de documento: Article